StockNews.com initiated coverage on shares of Sypris Solutions (NASDAQ:SYPR – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the auto parts company’s stock.
Sypris Solutions Trading Down 0.7 %
NASDAQ SYPR opened at $1.35 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.28 and a quick ratio of 0.45. The firm’s fifty day moving average price is $1.55 and its 200 day moving average price is $1.61. The company has a market capitalization of $31.01 million, a price-to-earnings ratio of -7.50 and a beta of 1.01. Sypris Solutions has a 12 month low of $1.27 and a 12 month high of $2.30.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Sypris Solutions stock. Williams & Novak LLC raised its holdings in Sypris Solutions, Inc. (NASDAQ:SYPR – Free Report) by 1.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,248,719 shares of the auto parts company’s stock after purchasing an additional 75,831 shares during the quarter. Sypris Solutions comprises approximately 7.6% of Williams & Novak LLC’s portfolio, making the stock its largest holding. Williams & Novak LLC owned about 18.66% of Sypris Solutions worth $8,158,000 as of its most recent SEC filing. 44.66% of the stock is owned by institutional investors.
Sypris Solutions Company Profile
Sypris Solutions, Inc engages in the provision of truck components, oil and gas pipeline components, and aerospace and defense electronics. It operates through Sypris Technologies and Sypris Electronics segments. The Sypris Technologies segment is involved in selling of forged, machined, welded, and heat-treated steel components primarily for the heavy commercial vehicle and high-pressure energy pipeline applications.
Featured Stories
- Five stocks we like better than Sypris Solutions
- Which Wall Street Analysts are the Most Accurate?
- Intel: Is Now the Time to Be Brave?Â
- Earnings Per Share Calculator: How to Calculate EPS
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What Investors Need to Know to Beat the Market
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Sypris Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sypris Solutions and related companies with MarketBeat.com's FREE daily email newsletter.